Decoy Therapeutics is trading at $1.24, up 5.97%, amid a biotech-sector rally.
- The sector context reports XBI up 2.20% during the regular session.
- No confirmed company-specific announcement explaining the October 15 move surfaced in the search results.
- Broader indexes were mixed: the Nasdaq fell 0.75%, while the Dow rose 0.71%, pointing more toward biotech-sector strength than a company catalyst.